search
Back to results

Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy

Primary Purpose

Obesity, Postoperative Pain, Postoperative Nausea

Status
Completed
Phase
Phase 4
Locations
Poland
Study Type
Interventional
Intervention
Dexmedetomidine Hydrochloride [Dexdor]
Remifentanil [Ultiva]
Ketamine [Ketalar]
Lidocaine [Xylocaine 2%]
Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]
Fentanyl [Fentanyl WZF]
Sponsored by
Medical University of Warsaw
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Opioid free anesthesia, Laparoscopic sleeve gastrectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Sleeve gastrectomy in patients with BMI > 40 or >35 with comorbidities
  • Written informed consent

Exclusion Criteria:

  • Patient's refusal
  • Known allergies to study medication
  • Inability to comprehend or participate In pain scoring scale
  • Inability to use intravenous patient controlled analgesia
  • Changes of operation extent during procedure
  • Revisional operations

Sites / Locations

  • Szpital Kliniczny Dzieciatka Jezus

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Opioid liberal group

Opioid free group

Arm Description

Outcomes

Primary Outcome Measures

Total postoperative oxycodone consumption
PCA (Patient's controlled analgesia) iv pump, oxycodone will be administered on patient's demand by 2mg boli, with lock out time 10 minutes
Postoperative pain score in NRS scale
NRS range from 0 for no pain to 10 for worst pain imaginable
Postoperative pain score in NRS scale
NRS range from 0 for no pain to 10 for worst pain imaginable
Postoperative pain score in NRS scale
NRS range from 0 for no pain to 10 for worst pain imaginable
Postoperative pain score in NRS scale
NRS range from 0 for no pain to 10 for worst pain imaginable

Secondary Outcome Measures

Postoperative sedation score
1-6 Ramsay sedation score; 1 - agitated or restless 6 - unresponsive
Postoperative nausea and vomiting
Simplified PONV impact scale 0-6 0 - no nausea nor vomiting 6 - >3 episodes of vomiting and nausea all of the time
Rescue fentanyl administration dosis
In opioid free group, rescue fentanyl dosis will be administered if hypertension > 140/90 mmHg or tachycardia > 120/min occurs
Highest BP
Highest BP during operation
Lowest BP
Lowest BP during operation
Highest HR
Highest HR during operation
Lowest HR
Lowest HR during operation
Total ephedrine dosis
Ephedrine is a vasopressor used in case of hypotension to maintain mean arterial pressure > 65 mmHg or to increase blood pressure to check surgical hemostasis
Postoperative desaturation
SpO2 < 94%
Patient's comfort assessed in QoR-40 formulary
QoR-40 scale is used to measure the quality of recovery after surgery and anesthesia, it is a 40 item questionnaire that provides a score across five dimensions: patient support, comfort, emotions, physical independence, and pain. Formulary will assess first 24 hours following the operation and will be filled by the patient 7 days after operation

Full Information

First Posted
January 29, 2020
Last Updated
March 7, 2023
Sponsor
Medical University of Warsaw
search

1. Study Identification

Unique Protocol Identification Number
NCT04260659
Brief Title
Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy
Official Title
Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy: Clinical, Randomised Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
February 4, 2020 (Actual)
Primary Completion Date
October 6, 2022 (Actual)
Study Completion Date
February 22, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Medical University of Warsaw

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Opioid free anesthesia is an anesthetic technique, in which administration of multimodal analgesia and sympathicolytics provides hemodynamic stability without use of opioids. Such management may be beneficial to the obese patients undergoing laparoscopic sleeve gastrectomy. Our study aims to compare opioid free anesthesia in such patients with standard, short-acting opioid based.
Detailed Description
The study has been approved by Bioethical Committee of Medical University of Warsaw. Informed written consent will be obtained from all patients. Sample size of 60 patients has been calculated based on the Altman normogram to obtain 30% reduction of postoperative opioid consumption with significance and power of 90%. Consenting patients scheduled for laparoscopic sleeve gastrectomy will be randomly assigned to the computer generated list to receive opioid free or standard opioid based anesthesia. Opioid free protocol includes administration of dexmedetomidine, lidocaine, ketamine, magnesium sulphate whereas standard group will receive remifentanil TCI Minto Model. After the end of operation all of the patient will receive oxycodone and additional doses via PCA system for postoperative analgesia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Postoperative Pain, Postoperative Nausea, Postoperative Vomiting, Opioid Use
Keywords
Opioid free anesthesia, Laparoscopic sleeve gastrectomy

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
59 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Opioid liberal group
Arm Type
Active Comparator
Arm Title
Opioid free group
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Dexmedetomidine Hydrochloride [Dexdor]
Intervention Description
Initial dosis of dexmedetomidine 1 mcg/kg IBW iv will be administered within 10 minutes before general anesthesia induction. Following intubation infusion of 1 mcg/kg IBW / h will be initiated and continued until the end of operation.
Intervention Type
Drug
Intervention Name(s)
Remifentanil [Ultiva]
Intervention Description
Remifentanil TCI Minto Model will be used during induction in dosis 6 ng/ml and intraoperatively appropriately to maintain hemodynamical stability.
Intervention Type
Drug
Intervention Name(s)
Ketamine [Ketalar]
Intervention Description
Ketamine 0,5mg/kg IBW iv will be administered during induction of general anesthesia.
Intervention Type
Drug
Intervention Name(s)
Lidocaine [Xylocaine 2%]
Intervention Description
Initial dosis of lidocaine 1,5 mg/kg IBW iv will be administered within 10 minutes before general anesthesia induction. Following intubation infusion of 3 mg/kg IBW / h will be initiated and continued until the end of operation.
Intervention Type
Drug
Intervention Name(s)
Magnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]
Intervention Description
Magnesium Sulphate will be administered in dosis 50 mg/kg IBW iv intraoperatively.
Intervention Type
Drug
Intervention Name(s)
Fentanyl [Fentanyl WZF]
Intervention Description
Rescue dosis of 100 mcg iv will be administered if hypertension > 140/90 mmHg or tachycardia > 120min occurs. If necessary rescue dosis may be repeated.
Primary Outcome Measure Information:
Title
Total postoperative oxycodone consumption
Description
PCA (Patient's controlled analgesia) iv pump, oxycodone will be administered on patient's demand by 2mg boli, with lock out time 10 minutes
Time Frame
Day "0"
Title
Postoperative pain score in NRS scale
Description
NRS range from 0 for no pain to 10 for worst pain imaginable
Time Frame
Day "0", assessed 1 hour after operation
Title
Postoperative pain score in NRS scale
Description
NRS range from 0 for no pain to 10 for worst pain imaginable
Time Frame
Day "0", assessed 6 hours after operation
Title
Postoperative pain score in NRS scale
Description
NRS range from 0 for no pain to 10 for worst pain imaginable
Time Frame
Day "0", assessed 12 hours after operation
Title
Postoperative pain score in NRS scale
Description
NRS range from 0 for no pain to 10 for worst pain imaginable
Time Frame
Day "1" assessed 24 hours after operation
Secondary Outcome Measure Information:
Title
Postoperative sedation score
Description
1-6 Ramsay sedation score; 1 - agitated or restless 6 - unresponsive
Time Frame
Day "0", assessed 1,6,12 and 24 hours after operation
Title
Postoperative nausea and vomiting
Description
Simplified PONV impact scale 0-6 0 - no nausea nor vomiting 6 - >3 episodes of vomiting and nausea all of the time
Time Frame
Day "0", assessed 1,6,12 and 24 hours after operation
Title
Rescue fentanyl administration dosis
Description
In opioid free group, rescue fentanyl dosis will be administered if hypertension > 140/90 mmHg or tachycardia > 120/min occurs
Time Frame
intraoperative
Title
Highest BP
Description
Highest BP during operation
Time Frame
intraoperative
Title
Lowest BP
Description
Lowest BP during operation
Time Frame
intraoperative
Title
Highest HR
Description
Highest HR during operation
Time Frame
intraoperative
Title
Lowest HR
Description
Lowest HR during operation
Time Frame
intraoperative
Title
Total ephedrine dosis
Description
Ephedrine is a vasopressor used in case of hypotension to maintain mean arterial pressure > 65 mmHg or to increase blood pressure to check surgical hemostasis
Time Frame
intraoperative
Title
Postoperative desaturation
Description
SpO2 < 94%
Time Frame
Day "0", assessed 1,6,12 and 24 hours after operation
Title
Patient's comfort assessed in QoR-40 formulary
Description
QoR-40 scale is used to measure the quality of recovery after surgery and anesthesia, it is a 40 item questionnaire that provides a score across five dimensions: patient support, comfort, emotions, physical independence, and pain. Formulary will assess first 24 hours following the operation and will be filled by the patient 7 days after operation
Time Frame
7 days postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Sleeve gastrectomy in patients with BMI > 40 or >35 with comorbidities Written informed consent Exclusion Criteria: Patient's refusal Known allergies to study medication Inability to comprehend or participate In pain scoring scale Inability to use intravenous patient controlled analgesia Changes of operation extent during procedure Revisional operations
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Piotr Mieszczański, MD
Organizational Affiliation
Medical University of Warsaw
Official's Role
Principal Investigator
Facility Information:
Facility Name
Szpital Kliniczny Dzieciatka Jezus
City
Warsaw
ZIP/Postal Code
02-005
Country
Poland

12. IPD Sharing Statement

Plan to Share IPD
Yes

Learn more about this trial

Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy

We'll reach out to this number within 24 hrs